A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
Observational Model: Cohort, Time Perspective: Prospective
Assess the ability of a mononuclear-cell gene signature to predict the presence of metastatic cancer in the regional L.N. of patients with muscle-invasive bladder cancer at the time of cystectomy with PLND for presumed localized muscle-invasive disease.
Guido Dalbagni, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|
|New York Presbyterian Hospital-Weill Medical College of Cornell University||New York, New York 10065|